Cpa3 - carboxypeptidase A3 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 54242
Summary
Predicted to enable metallocarboxypeptidase activity. Predicted to be involved in proteolysis. Predicted to act upstream of or within regulation of angiotensin levels in blood. Predicted to be located in transport vesicle. Predicted to be active in extracellular space. Orthologous to human CPA3 (Carboxypeptidase A3). [provided by Alliance of Genome Resources, Apr 2022]
Cpa3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_019300.1 | NP_062173.1 | mast cell carboxypeptidase A precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
mast cell carboxypeptidase A |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-70005 | CPA inhibitor | 99.78% | Unkown | |
| HY-RS03082 | CPA3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS03083 | CPA4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service